GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » EV-to-EBITDA

Ectin Research AB (XSAT:ECTIN B) EV-to-EBITDA : -0.21 (As of Jun. 18, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ectin Research AB's enterprise value is kr3.50 Mil. Ectin Research AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was kr-16.88 Mil. Therefore, Ectin Research AB's EV-to-EBITDA for today is -0.21.

The historical rank and industry rank for Ectin Research AB's EV-to-EBITDA or its related term are showing as below:

XSAT:ECTIN B' s EV-to-EBITDA Range Over the Past 10 Years
Min: -0.45   Med: 0   Max: 1.22
Current: -0.21

During the past 4 years, the highest EV-to-EBITDA of Ectin Research AB was 1.22. The lowest was -0.45. And the median was 0.00.

XSAT:ECTIN B's EV-to-EBITDA is ranked worse than
100% of 450 companies
in the Biotechnology industry
Industry Median: 9.11 vs XSAT:ECTIN B: -0.21

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-18), Ectin Research AB's stock price is kr0.525. Ectin Research AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-1.340. Therefore, Ectin Research AB's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Ectin Research AB EV-to-EBITDA Historical Data

The historical data trend for Ectin Research AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB EV-to-EBITDA Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
EV-to-EBITDA
- - 0.16 0.07

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.25 0.16 0.07 -0.30

Competitive Comparison of Ectin Research AB's EV-to-EBITDA

For the Biotechnology subindustry, Ectin Research AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ectin Research AB's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ectin Research AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ectin Research AB's EV-to-EBITDA falls into.



Ectin Research AB EV-to-EBITDA Calculation

Ectin Research AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3.504/-16.882
=-0.21

Ectin Research AB's current Enterprise Value is kr3.50 Mil.
Ectin Research AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-16.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ectin Research AB  (XSAT:ECTIN B) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Ectin Research AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.525/-1.340
=At Loss

Ectin Research AB's share price for today is kr0.525.
Ectin Research AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.340.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Ectin Research AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ectin Research AB (XSAT:ECTIN B) Business Description

Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines